FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

AdvaMed Comments on Electronic Submission Guide

[ Price : $8.95]

AdvaMed raises concerns about an FDA draft guidance on De Novo electronic submissions.

Concerns About FDA QMM Program

[ Price : $8.95]

The Association for Accessible Medicines raises several issues and concerns with FDAs proposal to develop a quality management mat...

Durbin, Grassley Push Drug Ad Transparency Bill

[ Price : $8.95]

Sen. Mike Crapo blocks an attempt by Sens. Dick Durbin and Charles Grassley to get unanimous consent to approve their bipartisan d...

FDA Opens Drug Supply Chain Security Act Portal

[ Price : $8.95]

FDA launches a Drug Supply Chain Security Portal as part of the CDER Next Gen Portal.

FDA Denies Apixaban ANDA Petition for Safety

[ Price : $8.95]

FDA denies for reasons of safety a 2017 petition seeking approval to submit an ANDA for a generic form of Bristol-Myers Squibbs El...

SCA Pharma Issued 10-Item FDA-483

[ Price : $8.95]

FDA posts a 10-item Form FDA-483 related to an inspection last month at SCA Pharmaceuticals Windsor, CT outsourcing facility.

Regulatory Review Determinations on 8 NDAs

[ Price : $8.95]

Federal Register notices: FDA publishes notices about the regulatory review period determinations for eight drug products sponsore...

Karuna NDA for Schizophrenia Accepted by FDA

[ Price : $8.95]

FDA accepts for review a Karuna Therapeutics NDA for KarXT (xanomeline-trospium) for treating schizophrenia in adults.

Praise for Graft-Versus-Host Drug Guidance

[ Price : $8.95]

Stakeholders comment positively on an FDA draft guidance on developing products to prevent or treat graft-versus-host disease.

FDA Studies Nasal Spray Distribution

[ Price : $8.95]

A CDER study examines generic nasal spray distribution factors that could speed the development of generic sprays.